HARVARD BIOSCIENCE INC — Director's Dealing 2014

Jun 3, 2014

SEC Form 4/A — Form 4/A

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2014-05-29

Reporting Person: HARTE NEAL J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-05-29	Common Stock	M	13317	$3.82	Acquired	37575	Direct
2014-05-29	Common Stock	S	12317	$4.27	Disposed	25258	Direct
2014-05-30	Common Stock	A	19400	—	Acquired	44658	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-29	Stock option (right to buy)	$3.82	M	13317	Disposed	2014-06-21	Common stock, par value $0.01 per share (13317)	Direct

Footnotes

F1: Represents shares sold to cover the exercise price of the option as part of a broker-assisted cashless exercise.

F2: Includes a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015.

F3: Includes (a) a deferred stock award of 19,400 restricted stock units which shall fully vest on May 30, 2015; and (b) a deferred stock award of 3,688 restricted stock units which shall fully vest on June 1, 2015; and (c) 21,570 shares of common stock held by the Reporting Person.

F4: The options vested in three equal installments on June 21, 2005, 2006 and 2007.

F5: This transaction was executed in multiple trades at prices ranging from $4.2647 to $4.2721. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.